People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elucida Oncology, Inc. | — | Biotechnology | Series B | $117.1M | $255.6M | 2020 |
| Omeza Holdings, Inc. | — | Other Health Care | Series A | $13.8M | $3.7M | 2022 |
| Omeza, LLC | — | Other Health Care | Series A | $10.8M | $79.4M | 2019 |
Robert Essner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Essner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas Gardner | 2 | 6 |
| Joel Morganroth | 2 | 2 |
| AG Lafley | 2 | 2 |
| Ronald Gelbman | 2 | 2 |
| Michael Smith | 1 | 20 |
| Isaac Blech | 1 | 14 |
| Robert Ruffolo | 1 | 8 |
| Michael T. Smith | 1 | 5 |
| Gary Sender | 1 | 3 |
| Tim Boris | 1 | 3 |
| Isaac A. Blech | 1 | 3 |
| Tim A. Boris | 1 | 2 |
| Cynthia Flowers | 1 | 2 |
| Richard Hague | 1 | 2 |
| Robert A. Essner | 1 | 1 |
| Steven Larson | 1 | 1 |
| Sigurdur A. Olafsson | 1 | 1 |
| Edward Rosen | 1 | 1 |
| Michelle A. Bradbury | 1 | 1 |
| Frank Martuci | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.